Katora (Sildenafil Citrate)

Sildenafil citrate selectively blocks the phosphodiesterase type 5 enzyme, leading to increased levels of cyclic GMP in smooth muscle cells. Higher cyclic GMP causes relaxation of blood vessels in the penis and lungs, enhancing blood flow and facilitating erection or reducing pulmonary arterial pressure.

The appropriate dose of Katora is determined by a qualified prescriber based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the dosing instructions provided by their healthcare professional and not adjust the dose on their own.

The safety of sildenafil citrate in pregnancy and lactation has not been established. It is generally not recommended for use by pregnant or nursing women unless the potential benefit outweighs the potential risk, as assessed by a healthcare provider.

To order Katora, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Katora (sildenafil citrate) belongs to the same class as other PDE5 inhibitors such as tadalafil and vardenafil. While all share the same mechanism of inhibiting PDE5, differences exist in onset of action, duration of effect, and dosing frequency, which clinicians consider when selecting the most appropriate therapy for a patient.

Katora should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture. Keep the product out of reach of children and avoid exposure to direct sunlight or excessive heat to maintain its stability.

Katora is taken orally, with or without food, as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not crushed or chewed. Onset of action typically occurs within 30 to 60 minutes.

Serious risks include priapism (a prolonged erection lasting more than four hours), sudden loss of vision, sudden loss of hearing, myocardial infarction, stroke, and severe hypotension. Patients experiencing any of these symptoms should seek immediate medical attention.

Katora should not be used by individuals who are taking nitrates, have had a recent heart attack or unstable angina, have severe hypotension, or have a known hypersensitivity to sildenafil citrate or any of the tablet’s excipients. A healthcare provider will assess suitability before prescribing.